Since the ARR2PB promoter is known to be inducible by androgen (e.g., dihydrotestosterone; DHT) [7], the LNCaP cell line was chosen specifically because it is one of the few prostate cancer cell lines available that express functional androgen receptor (AR). This evidence concerns the gene AR and prostate cancer.